182 related articles for article (PubMed ID: 15777256)
1. Genetically engineered bacteriocins and their potential as the next generation of antimicrobials.
Gillor O; Nigro LM; Riley MA
Curr Pharm Des; 2005; 11(8):1067-75. PubMed ID: 15777256
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in bacteriocin application as antimicrobials.
Gillor O; Ghazaryan L
Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):115-22. PubMed ID: 18221167
[TBL] [Abstract][Full Text] [Related]
3. Diversity of the bacteriocins, their classification and potential applications in combat of antibiotic resistant and clinically relevant pathogens.
Choi GH; Holzapfel WH; Todorov SD
Crit Rev Microbiol; 2023 Sep; 49(5):578-597. PubMed ID: 35731254
[TBL] [Abstract][Full Text] [Related]
4. Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance.
Hassan M; Kjos M; Nes IF; Diep DB; Lotfipour F
J Appl Microbiol; 2012 Oct; 113(4):723-36. PubMed ID: 22583565
[TBL] [Abstract][Full Text] [Related]
5. [Molecular basis of bacteriocins production and activity].
Blinkova LP; Al'tshuler ML; Dorofeeva ES; Gorobets OB
Zh Mikrobiol Epidemiol Immunobiol; 2007; (2):97-104. PubMed ID: 17523491
[TBL] [Abstract][Full Text] [Related]
6. Bacteriocins from plant pathogenic bacteria.
Holtsmark I; Eijsink VG; Brurberg MB
FEMS Microbiol Lett; 2008 Mar; 280(1):1-7. PubMed ID: 18070073
[TBL] [Abstract][Full Text] [Related]
7. Bacteriocins active against plant pathogenic bacteria.
Grinter R; Milner J; Walker D
Biochem Soc Trans; 2012 Dec; 40(6):1498-502. PubMed ID: 23176505
[TBL] [Abstract][Full Text] [Related]
8. Bacteriocins and their position in the next wave of conventional antibiotics.
Cavera VL; Arthur TD; Kashtanov D; Chikindas ML
Int J Antimicrob Agents; 2015 Nov; 46(5):494-501. PubMed ID: 26341839
[TBL] [Abstract][Full Text] [Related]
9. The evolution of spectrum in antibiotics and bacteriocins.
Palmer JD; Foster KR
Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2205407119. PubMed ID: 36099299
[TBL] [Abstract][Full Text] [Related]
10. The dual role of bacteriocins as anti- and probiotics.
Gillor O; Etzion A; Riley MA
Appl Microbiol Biotechnol; 2008 Dec; 81(4):591-606. PubMed ID: 18853155
[TBL] [Abstract][Full Text] [Related]
11. Bacteriocins from lactic acid bacteria as an alternative to antibiotics.
Ołdak A; Zielińska D
Postepy Hig Med Dosw (Online); 2017 May; 71(0):328-338. PubMed ID: 28513457
[TBL] [Abstract][Full Text] [Related]
12. Bacteriocins: Potential for Human Health.
Huang F; Teng K; Liu Y; Cao Y; Wang T; Ma C; Zhang J; Zhong J
Oxid Med Cell Longev; 2021; 2021():5518825. PubMed ID: 33936381
[TBL] [Abstract][Full Text] [Related]
13. Turning Over a New Leaf: Bacteriocins Going Green.
Ghequire MGK; De Mot R
Trends Microbiol; 2018 Jan; 26(1):1-2. PubMed ID: 29150081
[TBL] [Abstract][Full Text] [Related]
14. Strategies for screening, purification and characterization of bacteriocins.
Zou J; Jiang H; Cheng H; Fang J; Huang G
Int J Biol Macromol; 2018 Oct; 117():781-789. PubMed ID: 29870810
[TBL] [Abstract][Full Text] [Related]
15. A phylogenetic approach to assessing the targets of microbial warfare.
Riley MA; Goldstone CM; Wertz JE; Gordon D
J Evol Biol; 2003 Jul; 16(4):690-7. PubMed ID: 14632232
[TBL] [Abstract][Full Text] [Related]
16. Lantibiotic resistance.
Draper LA; Cotter PD; Hill C; Ross RP
Microbiol Mol Biol Rev; 2015 Jun; 79(2):171-91. PubMed ID: 25787977
[TBL] [Abstract][Full Text] [Related]
17. Diversified transporters and pathways for bacteriocin secretion in gram-positive bacteria.
Zheng S; Sonomoto K
Appl Microbiol Biotechnol; 2018 May; 102(10):4243-4253. PubMed ID: 29560521
[TBL] [Abstract][Full Text] [Related]
18. Bacteriocins: perspective for the development of novel anticancer drugs.
Baindara P; Korpole S; Grover V
Appl Microbiol Biotechnol; 2018 Dec; 102(24):10393-10408. PubMed ID: 30338356
[TBL] [Abstract][Full Text] [Related]
19. Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology.
Mills S; Ross RP; Hill C
FEMS Microbiol Rev; 2017 Aug; 41(Supp_1):S129-S153. PubMed ID: 28830091
[TBL] [Abstract][Full Text] [Related]
20. Engineering Artificial Biodiversity of Lantibiotics to Expand Chemical Space of DNA-Encoded Antibiotics.
Pipiya SO; Terekhov SS; Mokrushina YA; Knorre VD; Smirnov IV; Gabibov AG
Biochemistry (Mosc); 2020 Nov; 85(11):1319-1334. PubMed ID: 33280576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
